FindTrial
Sign In

Study on the Therapeutic Efficacy of Ultrasound-Guided Erector Spinae Plane Block for Chronic Non-Specific Low Back Pain and the Construction of a Short-Term Efficacy Prediction Model

Study on the Therapeutic Efficacy of Ultrasound-Guided Erector Spinae Plane Block for Chronic Non-Specific Low Back Pain and the Construction of a Short-Term Efficacy Prediction Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118332
Enrollment
Unknown
Registered
2026-02-04
Start date
2023-10-06
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Non-Specific Low Back

Interventions

Intervention group:None
Control group:None
Observation group :None

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18~65 years old, gender is not limited. 2. Meet the diagnostic criteria of CNLBP; 3. Stable symptoms without acute exacerbation; 4. Pain visual analogue score (VAS) >=4; 5. No interventional therapy (e.g., closed injection, radiofrequency ablation) in the last 3 months; 6. Voluntarily sign the informed consent and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Specific low back pain with a clear diagnosis (e.g. lumbar disc herniation, infection, tumour, etc.). 2. Patients with acute and sub-acute stages of pain, i.e. the duration of low back pain is less than 12 weeks. 3. Combined with serious cardiovascular and cerebrovascular diseases, liver and renal insufficiency or malignant tumours. 4. History of lumbar spine surgery, ankylosing spondylitis. 5. Patients in lactation or pregnancy. 6. Allergy to local anaesthetics (ropivacaine) or glucocorticoids (triamcinolone acetonide). 7. Presence of severe coagulation disorders or infections. 8. Presence of mental illness or inability to complete scale assessments (e.g., severe cognitive impairment). 9. Patients who are unable to co-operate with treatment and complete the four-week follow-up. 10. Lower limb injuries. 11. Severe osteoporosis. 12. Underlying systemic and specific diseases. 13. Systemic rheumatic diseases. 14. Specific psychological problems.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale, VAS;Oswestry Disability Index, ODI;Area Under the Receiver Operating Characteristic Curve;—

Secondary

MeasureTime frame
Short Form 36 Health Survey,SF-36;Self-Rating Depressive Scale, SDS;Self- Rating Anxiety Scale, SAS;the mean thickness of the painful-side erector spinae at the L3-L5 spinal levels; the mean thickness of the painful-side multifidus muscles at the L3-L5 spinal levels;Calibration curves;Decision curve analysis;—

Countries

China

Contacts

Public ContactQixin Lan

The First Affiliated Hospital of Guangxi Medical University

lanqixin158@qq.com+86 771 530 1823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026